Clariant Reports Improved Q2 Results; Sees Growth Extending To Q3

Specialty chemical company Clariant AG (CRN.L) on Thursday announced 12% increase in sales from continuing operations in the second quarter to CHF 1.032 billion from CHF926 million last year, driven by sales growth in all regions, reflecting a demand recovery.

EBITDA for the quarter rose to CHF173 million from CHF135 million a year ago.

EBITDA, excluding items, was CHF178 million compared with CHF146 million last year.

Net result from continuing operations for the first half rose to CHF107 million from CHF75 million during the prior-year period.

For the third quarter, Clariant said it expects continued strong growth for the Group in local currency versus the prior year

Looking forward to the full year 2021, Clariant expects to achieve local currency sales growth in continuing operations in a range of 7 % - 9 %.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
General Motors will start replacing defective battery modules in Chevrolet Bolt EVs and EUVs with new modules. The replacement battery modules will be shipped to dealers as soon as mid-October, the automaker said in a statement. CVS Health is set to recruit qualified candidates to fill 25,000 clinical and retail jobs during a one-day national career event on Friday, September 24. This will enable CVS to meet the high demand for pharmacists, pharmacy technicians, nurses, and retail store associates to support flu season, COVID-19 vaccinations and testing. Twitter, Inc. (TWTR) announced Monday that it has entered into a binding agreement to settle the consolidated class action lawsuit commenced in 2016 in the United States District Court for the Northern District of California. Under the terms of the proposed settlement, Twitter will pay $809.5 million...
Follow RTT